Bristol-Myers Squibb

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Bristol-Myers Squibb 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BMY

Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. 

CEO
Christopher S. Boerner
CEOChristopher S. Boerner
Employees
32,500
Employees32,500
Headquarters
Princeton, New Jersey
HeadquartersPrinceton, New Jersey
Founded
1933
Founded1933
Employees
32,500
Employees32,500

BMY Key Statistics

Market cap
120.44B
Market cap120.44B
Price-Earnings ratio
13.20
Price-Earnings ratio13.20
Dividend yield
4.23%
Dividend yield4.23%
Average volume
9.50M
Average volume9.50M
High today
$59.35
High today$59.35
Low today
$57.88
Low today$57.88
Open price
$59.26
Open price$59.26
Volume
5.91M
Volume5.91M
52 Week high
$68.64
52 Week high$68.64
52 Week low
$45.27
52 Week low$45.27

Stock Snapshot

As of today, Bristol-Myers Squibb(BMY) shares are valued at $58.92. The company's market cap stands at 120.44B, with a P/E ratio of 13.20 and a dividend yield of 4.23%.

As of 2026-11-19, Bristol-Myers Squibb(BMY) stock has fluctuated between $57.88 and $59.35. The current price stands at $58.92, placing the stock +1.8% above today's low and -0.7% off the high.

The Bristol-Myers Squibb(BMY)'s current trading volume is 5.91M, compared to an average daily volume of 9.5M.

During the past year, Bristol-Myers Squibb(BMY) stock moved between $45.27 at its lowest and $68.64 at its peak.

During the past year, Bristol-Myers Squibb(BMY) stock moved between $45.27 at its lowest and $68.64 at its peak.

BMY News

Investing.com 10h
Evotec shares rise after second IND acceptance with Bristol Myers - Investing.com

...

Evotec shares rise after second IND acceptance with Bristol Myers - Investing.com
The Motley Fool 23h
Bristol-Myers Squibb: 3 Key Takeaways for Long-Term Investors

Free Article Explore Premium Services Bristol-Myers Squibb: 3 Key Takeaways for Long-Term Investors A $1.5 billion to $2 billion revenue cliff looms in 2027, ye...

Bristol-Myers Squibb: 3 Key Takeaways for Long-Term Investors
Simply Wall St 6d
Have Insiders Sold Bristol-Myers Squibb Shares Recently?

Anyone interested in Bristol-Myers Squibb Company ( ) should probably be aware that the Independent Director, Julia Haller, recently divested US$241k worth of s...

Have Insiders Sold Bristol-Myers Squibb Shares Recently?

Analyst ratings

60%

of 30 ratings
Buy
33.3%
Hold
60%
Sell
6.7%

People also own

Based on the portfolios of people who own BMY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.